Targeted Oncology™ Community Case Forum™
Thursday September 11, 2025 | 5:45 - 8:30 PM CT
The Royal Sonesta Minneapolis Downtown | Minneapolis, MN
CONNECT WITH THE COMMUNITY
The Community Case Forum is a special opportunity to gather IN-PERSON only.
No virtual options are available.
After arriving at registration check-in, you'll spend some time networking with peers while enjoying small plate refreshments and cocktails. Case-based discussions will follow the networking reception and the evening will adjourn by 8:30 PM.
Eligibility
Participants must be medical oncologists or hematologists currently treating patients in a community practice setting. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend.
Discussion Topics
You choose the topic that is best aligned for the patients you're seeing in your practice now. Our moderators will present case-based clinical profiles to generate discussion among participants around recent clinical data and potential treatment strategies.
*Registration is now closed due to reaching capacity.*
Discussion Topics Include:
Prostate Cancer: Castration-Resistant
During this conversation we will cover two clinical cases of CRPC: one non-metastatic and one metastatic.
Moderated by: Emmanuel Antonarakis, MD (University of Minnesota, Masonic Cancer Center)
Emerging Strategies in the Therapeutic Sequencing of Metastatic Breast Cancer
During this conversation we will explore two cases that will foster a discussion of how we are sequencing antibody-drug conjugates in our treatment plans for patients with HER2-negative metastatic breast cancer.
Moderated by: Roberto A. Leon-Ferre, MD (Mayo Clinic)
MARKET RESEARCH PARTICIPATION
Seating is limited, and registration will close when capacity is reached.
Reserve your seat today for the Targeted Oncology Community Case Forum.
Presented in Partnership With:
Targeted Healthcare Communications® — an MJH Life Sciences® Brand
Copyright 2025 © Intellisphere, LLC. All Rights Reserved.